Challenges in the Use of Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer
Open Access
- 1 October 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 11 (9) , 1010-1017
- https://doi.org/10.1634/theoncologist.11-9-1010
Abstract
Learning Objectives: After completing this course, the reader will be able to: Describe the activity of EGFR inhibitors in metastatic colorectal cancer.Discuss planned studies.Discuss adverse events of EGFR inhibitors. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.comKeywords
This publication has 26 references indexed in Scilit:
- Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitorsAnnals of Oncology, 2005
- Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignanciesInvestigational New Drugs, 2005
- Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by ImmunohistochemistryJournal of Clinical Oncology, 2005
- VEGF-Targeted Therapy in Metastatic Renal Cell CarcinomaThe Oncologist, 2005
- Epidermal growth factor receptor inhibition strategies in oncologyEndocrine-Related Cancer, 2004
- Epidermal Growth Factor Receptor (EGFR) Status in Primary Colorectal Tumors Does Not Correlate With EGFR Expression in Related Metastatic Sites: Implications for Treatment With EGFR-Targeted Monoclonal AntibodiesJournal of Clinical Oncology, 2004
- Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II TrialJournal of Clinical Oncology, 2004
- Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor ReceptorJournal of Clinical Oncology, 2004
- Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of CancerJournal of Clinical Oncology, 2003
- EGF receptorThe International Journal of Biochemistry & Cell Biology, 1999